Here are four notes:
1. In the task force’s October 2015 draft guidelines, they recommended Cologuard as an “alternate” to other screening tests.
2. The task force clarified Cologuard’s standing in its final recommendation statement.
3. The task force acknowledges “there is no ‘one size fits all’ approach to colorectal cancer screening” and that it “seeks to provide clinicians and patients with the best possible evidence about the various screening methods to enable informed, individual decision making.”
4. The final recommendations also recognize the use of Cologuard every three years.
More articles on GI/endoscopy:
Lowcountry Gastroenterology Associates adds Dr. William Bulsiewicz — 5 points
Healthmark releases Now! test for ensuring endoscope safety: 3 points
Gastroenterologist to know: Dr. Christopher Forsmark of University of Florida
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.